Marienhospital Bottrop

Hospital


Location: Bottrop, Germany (DE) DE

ISNI: -

ROR: https://ror.org/02d6kbk83

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Update Breast Cancer 2022 Part 2 - Advanced Stage Breast Cancer (2022) Müller V, Welslau M, Lüftner D, Schütz F, Stickeler E, Fasching P, Janni W, et al. Journal article, Review article Update Breast Cancer 2022 Part 4 - Advanced-Stage Breast Cancer. (2022) Aktas B, Fehm TN, Welslau M, Mueller V, Lueftner D, Schuetz F, Fasching P, et al. Journal article, Review article Update Breast Cancer 2021 Part 4 - Prevention and Early Stages. (2022) Thomssen C, Fehm TN, Stickeler E, Fasching P, Janni W, Kolberg-Liedtke C, Kolberg HC, et al. Journal article, Review article Update Breast Cancer 2021 Part 5 - Advanced Breast Cancer. (2022) Lueftner D, Schuetz F, Stickeler E, Fasching P, Janni W, Kolberg-Liedtke C, Kolberg HC, et al. Journal article, Review article Update Breast Cancer 2022 Part 1 - Early Stage Breast Cancer. (2022) Welslau M, Mueller V, Lueftner D, Schuetz F, Stickeler E, Fasching P, Janni W, et al. Journal article, Review article Update Breast Cancer 2022 Part 3 - Early-Stage Breast Cancer. (2022) Fehm TN, Welslau M, Mueller V, Lueftner D, Schuetz F, Fasching P, Janni W, et al. Journal article, Review article Return of individual genomic research results within the PRAEGNANT multicenter registry study (2022) Hübner H, Rübner M, Kurbacher C, Hadji P, Hartkopf AD, Lux MP, Huober J, et al. Journal article Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients – Data from the Real-World Registry PRAEGNANT (2022) Engler T, Fasching P, Lueftner D, Hartkopf AD, Mueller V, Kolberg HC, Hadji P, et al. Journal article Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status (2021) Hein A, Hartkopf AD, Emons J, Lux MP, Volz B, Taran FA, Overkamp F, et al. Journal article Update Breast Cancer 2021 Part 3 – Current Developments in the Treatment of Early Breast Cancer: Review and Assessment of Specialised Treatment Scenarios by an International Expert Panel (2021) Fehm TN, Stickeler E, Fasching P, Janni W, Kolberg-Liedtke C, Kolberg HC, Lüftner D, et al. Journal article, Review article